Home » Newsletters » BioWorld Science

BioWorld Science

June 27, 2005

View Archived Issues

WT1-peptide vaccination proven effective in acute myeloid leukemia

Good results reported for deferasirox in transfusion-related iron overload

MedImmune and Avalon team up to treat inflammatory disease

Animal studies to test CytoGenix synthetic DNA vaccine against smallpox

Phase II data on MBX-102 reports efficacy without the side effects of weight gain and edema

Clinical analysis of Technosphere Insulin

Antidiabetic activity of SGL-0010 described

Long-term benefits of atorvastatin in patients with type 2 diabetes

Update on the antitumor effects of lenalidomide in hematological malignancies

Enrollment open in phase I/II study of HIV integrase inhibitor GS-9137

Enrollment completed in phase III PROTECT study of Provenge

Iclaprim shows potential for pneumonia in phase I study

IND-enabling animal safety studies for CT-322

Indaflex launched in Mexico

Encouraging interim analysis for phase II trial of ACP-103

BioLineRx inlicenses new compounds

BI-201 begins phase I/IIa studies for HIV

Positive phase II findings for TheraCLEC

Allon seeks clearance for clinical trials of AL-208

PDL sublicenses antibody-drug conjugate rights to Genentech

Antigen Express and Stallergenes partner on novel allergy therapy

Genelabs updates Prestara developmental status

Novel androgen receptor agonists emerge from Schering AG R&D

Novel agents for AIDS imparted by ViroChem

Novel analgesic agents claimed in recent patent literature

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 23, 2025.
A fresh look at 1000 Genomes is more detailed, and more panoramic
BioWorld
The human genome has yielded another round of secrets with the publication of two back-to-back papers in Nature on July 23, 2025. Both studies re-sequenced...
Newco sends up Flare in bid to Dispatch solid tumors
BioWorld
Dispatch Biotherapeutics Inc. is taking aim at solid tumors with a new viral vector/antigen technology backed by major industry names such as Arch Venture...
GABRA5 modulation supports treatment of neurodevelopmental disorders
BioWorld Science
Alterations in the GABAergic pathway in the brain contribute to the pathophysiology of neurodevelopmental disorders, including autism spectrum disorder and...